Pharmaceutical Executive
April 01, 2013
Country Report
0
0
Belgium is a hub for clinical trials, a leader in the biopharmaceutical industry, and a center for pharmaceutical production and distribution.
April 01, 2013
Features
0
0
List pricing strategies that diverge from these approaches without "hitting the cliff".
April 01, 2013
Column
0
0
The European Union's attempt to update its transparency rules sparks new debate.
April 01, 2013
Features
0
0
The slow evolution toward a state of grace in tracking ROI for digital promotion.
April 01, 2013
Features
0
0
Improving the quality of clinical trials is a major strategic activity for Big Pharma, one where efficient management of a demanding set of regulatory requirements can have a positive impact on the bottom line.
April 01, 2013
Features
0
0
Pharm Exec's annual look at the trends and best practices in biopharm licensing and M&A for the year ahead.
April 01, 2013
Features
0
0
This year's HBA Woman of the Year is Merck's Bridgette Heller of Merck Consumer Care.
April 01, 2013
Column
0
0
Take a page from the consumer marketing playbook and promote a product's advantage and why it should matter to the customer.
April 01, 2013
From the Editor
0
0
The conversation thread that binds this month's Pharm Exec is building communities-when the harsh economics of market change suddenly discounts the familiar, then the best way to move up is to reach out.
April 01, 2013
Column
0
0
There seems no end to demands for data on clinical research, conflicts of interest, company payments, and drug prices.